As we continue our Big4Bio occasional series on discovery and safety assessment with Charles River Labs, we explore new approach methodologies, or NAMs, and their integration with antibody discovery and development. We spoke to Charles River Laboratories’ Senior Principal Scientific Advisor Sarah Gould and Charles River Laboratories’ Scientific Business Director Omar Aziz about the evolving landscape of predictive toxicology, regulatory efforts to advance alternatives to animal testing, and the role of collaboration and strategy in accelerating therapeutic programs from concept to the clinic.

Episode ID: 1000737377515

GUID: tag:soundcloud,2010:tracks/2211388271

Release Date: 19/11/2025, 13:30:07